- Drug initially developed by largest academic clinical research organization in the world.
- Drug addresses a multi-billion-dollar market.
- Drug currently in Phase III testing.
- Interim data events coming in second quarter 2014.
Regado Biosciences is pioneering a new therapeutic technology with the creation and development of two-component drug systems. Each system comprises a nuclease-stabilized RNA aptamer that can be controlled directly by its specific and complementary oligonucleotide active control agent. This... More